Products with Anticancer bioactivity
| Cat.No. | Product Name |
|---|---|
| BCN6712 | Yadanzioside M |
| 1. Yadanzioside M has antitumor activity. | |
| BCN6734 | Walsuralactam A |
| 1. Walsuralactam A in the formula I, which is used as an active ingredient, and is used for treating and preventing the tumour. | |
| BCN6762 | Trimethoxystilbene |
| 3,4',5-Trimethoxystilbene, an inhibitor of tubulin polymerization, which exerts antitumor, anti-HCV, antiallergic, anti-mitotic properties, it also exerts antiangiogenic and vascular-disrupting effects in zebrafish through the downregulation of VEGFR2 and cell-cycle modulation. 3,4',5-Trimethoxystilbene has anti-inflammatory activity, the ability of it to induce HO-1 expression may provide one of possible mechanisms of its anti-inflammatory action. | |
| BCN6778 | Tryprostatin A |
| 1. Tryprostatin A and tryprostatin B are indole alkaloid-based fungal products that inhibit mammalian cell cycle at the G2/M phase. 2. Tryprostatin A is an inhibitor of breast cancer resistance protein. | |
| BCN8446 | Mogrol |
| Mogrol has exhibited anti-cancer activities, it suppressed leukemia cell growth via inhibition of the ERK1/2 and STAT3 pathways, in particular, through the suppression of p-ERK1/2 and p-STAT3. Mogrol significantly improved LPS-induced memory impairment in mice. It also suppressed adipogenesis by reducing CREB activation in the initial stage of cell differentiation and by activating AMPK signaling in both the early and late stages of this process. | |
